Cargando…

Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy

BACKGROUND: Myocardial scar burden quantified using late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR), has important prognostic value in hypertrophic cardiomyopathy (HCM). However, nearly 50% of HCM patients have no scar but undergo repeated gadolinium-based CMR over their li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fahmy, Ahmed S., Rowin, Ethan J., Arafati, Arghavan, Al-Otaibi, Talal, Maron, Martin S., Nezafat, Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235098/ https://www.ncbi.nlm.nih.gov/pubmed/35761339 http://dx.doi.org/10.1186/s12968-022-00869-x

Ejemplares similares

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Improved Quantification of Myocardium Scar in Late Gadolinium Enhancement Images: Deep Learning Based Image Fusion Approach
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

The necessity for full ventricular coverage with noncontrast T1 mapping in hypertrophic cardiomyopathy
por: Rowin, Ethan, et al.
Publicado: (2013)

Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
por: Maron, Martin S, et al.
Publicado: (2023)

Winter Is Coming: The Slippery Slope of Defining Disease and the Implications for Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2022)

Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Noncontrast T1 values do not correlate to clinically relevant variables in patients with hypertrophic cardiomyopathy
por: Rowin, Ethan, et al.
Publicado: (2013)

What Causes Hypertrophic Cardiomyopathy?
por: Maron, Bradley A., et al.
Publicado: (2022)

Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience
por: Weinstock, Jonathan, et al.
Publicado: (2016)

Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
por: Maron, Barry J., et al.
Publicado: (2022)

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Echocardiography as a Screening Test for Myocardial Scarring in Children with Hypertrophic Cardiomyopathy
por: Compton, Gregory, et al.
Publicado: (2016)

Echocardiographic profiles in hypertrophic cardiomyopathy: imaging beyond the septum and systolic anterior motion
por: Pandian, Natesa G, et al.
Publicado: (2015)

Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2019)

Thinking Outside the Heart to Treat Atrial Fibrillation in Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2020)

Scar heterogeneity in hypertrophic cardiomyopathy. Comparison with chronic myocardial infarction and normal subjects
por: Vianello, Pier Filippo, et al.
Publicado: (2014)

Altered intercellular communication and extracellular matrix signaling as a potential disease mechanism in human hypertrophic cardiomyopathy
por: Larson, Amy, et al.
Publicado: (2022)

Clinical Characteristics and Healthcare Resource Utilization among Patients with Obstructive Hypertrophic Cardiomyopathy Treated in a Range of Settings in the United States
por: Butzner, Michael, et al.
Publicado: (2022)

Association Between Left Ventricular Mechanical Deformation and Myocardial Fibrosis in Nonischemic Cardiomyopathy
por: Csecs, Ibolya, et al.
Publicado: (2020)

Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
por: Maron, Bradley A., et al.
Publicado: (2021)

Diffuse Myocardial Fibrosis detected by Multi-slice T(1) Mapping using Slice Interleaved T(1) (STONE) Sequence in Patients with Hypertrophic Cardiomyopathy
por: Kato, Shingo, et al.
Publicado: (2016)

Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy
por: Neisius, Ulf, et al.
Publicado: (2019)

Interpretable machine learning for automated left ventricular scar quantification in hypertrophic cardiomyopathy patients
por: Navidi, Zeinab, et al.
Publicado: (2023)

Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
por: Maron, Bradley A., et al.
Publicado: (2022)

Cardiac Sarcoidosis Mimicking Hypertrophic Cardiomyopathy: The Importance of Cardiac Magnetic Resonance Imaging
por: Feldman, Daniel R., et al.
Publicado: (2020)

Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation
por: Larson, Amy, et al.
Publicado: (2021)

Relationship between myocardial scar and hypertrophy by LGE CMR in hypertrophic cardiomyopathy patients with and without clinical events
por: Kino, Aya, et al.
Publicado: (2012)

Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with “pure” apical hypertrophic cardiomyopathy
por: Kim, Kyung-Hee, et al.
Publicado: (2012)

High Sensitivity of Late Gadolinium Enhancement for Predicting Microscopic Myocardial Scarring in Biopsied Specimens in Hypertrophic Cardiomyopathy
por: Konno, Tetsuo, et al.
Publicado: (2014)

Gray blood late gadolinium enhancement cardiovascular magnetic resonance for improved detection of myocardial scar
por: Fahmy, Ahmed S., et al.
Publicado: (2018)

Performance of 12‐lead electrocardiogram Selvester QRS scoring criteria to diagnose myocardial scar in patients with hypertrophic cardiomyopathy
por: Chen, Shi, et al.
Publicado: (2020)

Exercise and myocardial injury in hypertrophic cardiomyopathy
por: Cramer, G Etienne, et al.
Publicado: (2020)

Aortic biomechanics in hypertrophic cardiomyopathy
por: Badran, Hala Mahfouz, et al.
Publicado: (2015)

Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
por: Maron, Martin S
Publicado: (2012)

Out With the Old and in With the New: Not So Fast in Hypertrophic Cardiomyopathy
por: Maron, Martin S.
Publicado: (2019)

Image resampling and discretization effect on the estimate of myocardial radiomic features from T1 and T2 mapping in hypertrophic cardiomyopathy
por: Marfisi, Daniela, et al.
Publicado: (2022)

Automated analysis of cardiovascular magnetic resonance myocardial native T(1) mapping images using fully convolutional neural networks
por: Fahmy, Ahmed S., et al.
Publicado: (2019)

Stress cardiomyopathy in a patient with hypertrophic cardiomyopathy and myocardial bridging
por: Benavides, Miguel, et al.
Publicado: (2017)

Fully‑automated deep‑learning segmentation of pediatric cardiovascular magnetic resonance of patients with complex congenital heart diseases
por: Karimi-Bidhendi, Saeed, et al.
Publicado: (2020)

Screening for hypertrophic cardiomyopathy: a cost analysis of echocardiography, cardiac magnetic resonance and genetic testing
por: Hauser, Thomas H, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_6r7g5is23haqm647nt7guush7j